NewSelf review

NewSelf offers flat-price compounded semaglutide and tirzepatide, with three months of medication supplied upfront. That can make ongoing dose increases easier to budget, but its cancellation and payment terms are among the most restrictive public policies in this comparison. A monthly payment does not make the weight-loss plan a one-month commitment.

The current website also contains inconsistent product content, including unrelated skin-care copy on a tirzepatide page. For a woman choosing prescription care, those issues make the actual written prescription and purchase agreement especially important. This review evaluates the public program and policies.

Flat dose pricing with a three-month term

The homepage lists semaglutide at $134.99 per month and tirzepatide at $224.99 per month, with the same price across the advertised dose range. It also displays lower as-low-as amounts of $99.97 and $144.49. The public presentation does not fully resolve the conditions behind those lower figures, so they should not replace the regular flat rates in a flexible-cost comparison.

The refund policy says medical weight-loss programs require a three-month commitment, because three months of medication are provided upfront. This applies regardless of the selected payment arrangement. Choosing monthly installments therefore does not remove the term or the potential early-exit cost.

The policy says leaving before the three-month term is complete triggers an early-cancellation fee equal to the program's full retail monthly price. Ask which retail amount governs your order, particularly if an introductory discount or as-low-as offer applies. A cheap starting price can have a different exit calculation than expected.

Payments automatically renew monthly unless canceled through the password-protected dashboard. Before buying, clarify what happens after the first three months, how far in advance renewal must be stopped and when the next supply is sent to the pharmacy. The ability to turn off renewal does not automatically release the original payment commitment.

What is in the medication?

NewSelf lists compounded semaglutide with B12 or glycine, and compounded tirzepatide with B6 or glycine. These are not the approved branded manufacturer products. The additional ingredients and flat-price offer do not establish a superior outcome or make the finished compound FDA-approved.

The homepage advertises third-party testing by its 503A pharmacy partners. Ask for the assigned pharmacy, the actual preparation, concentration and label instructions. A general testing claim does not identify the pharmacy responsible for your prescription or establish that a prior provider's measuring instructions can be reused.

The tirzepatide page has noticeable editorial problems: its description calls the medicine GLP-2 in one place, then includes tallow-balm ingredients and skin-care questions unrelated to tirzepatide. Those inconsistencies do not prove the dispensed medication is wrong, but they reduce the usefulness of the product page as a reliable explanation of treatment. Obtain accurate written information directly from the prescribing clinician and dispensing pharmacy.

The site also uses broad marketing claims and trial-related weight-loss figures. Such figures should not be treated as a guaranteed result from NewSelf's specific preparation. Our compounded versus brand-name guide explains why ingredient similarity, testing claims and trial averages answer different questions.

Refunds before and after the consultation

A written cancellation before the medical consultation may qualify for a refund less a $99 administrative fee. Once the consultation is completed and a prescription is approved, the policy says it is immediately transmitted for fulfillment and the order becomes non-cancelable and non-refundable, regardless of shipment status.

If the clinician declines the prescription, the policy promises a full refund without the administrative fee. That is a specific exception and should not be confused with changing your mind after an approved consultation. Save the applicable terms before authorizing the initial payment.

Changing prescription type after pharmacy transmission carries a stated $150 reprocessing fee, with any modification still subject to clinical approval. If you are uncertain between medications, discuss the options before the order is finalized. An upfront three-month supply can make a later change more financially consequential than a smaller first shipment.

The policy also threatens a $199 processing fee for certain disputed charges and a 50% collection surcharge on unpaid committed balances. Those are the company's stated contractual claims, not a conclusion that every fee would be enforceable in every situation. They nevertheless signal that a buyer should understand the commitment and keep clear records before enrolling.

Availability, shipping and support

The FAQ says the service operates in forty-eight states and Puerto Rico, excluding Mississippi and Louisiana. The platform's general statement about access to physicians in all fifty states does not erase those medication-service exclusions. Confirm the actual prescription and pharmacy for your location.

NewSelf advertises cold overnight shipping and says it avoids Friday dispatch. The policy includes broad temperature-stability statements, but the dispensing pharmacy's instructions for your actual medication should govern handling. If the package is delayed or temperature exposure is uncertain, contact the pharmacy before deciding it is suitable to use.

Incorrect, damaged or delayed shipments must be reported within seven days of delivery or expected delivery. For a non-delivery claim, the policy generally requires a three-day waiting period beyond the estimated delivery date before replacement processing. An incorrect customer-entered address can lead to a $150 reprocessing and reshipping charge.

The reviewed offer does not publish a detailed women's-specific follow-up or routine laboratory pathway. Ask how to reach the prescribing clinician and what monitoring is expected, rather than assume a three-month supply means three months without clinical contact.

Women's-care fit and the decision

NewSelf does not establish a dedicated menopause HRT service or a complete PCOS program in the reviewed pages. A woman needing fertility care, menstrual management or coordinated hormone therapy should clarify those needs with her regular clinician. Our PCOS guide can help organize that broader plan.

The strongest feature is a visible regular rate that stays constant across doses. The largest drawbacks are the required three-month term, early non-refundable boundary, potential exit charges and unreliable product-page editing. Our provider-selection guide can help compare those conditions with a shorter commitment before accepting the apparent savings.